InteliQ Specialty Immunoassay Control is a ready-to-use quality control in a barcoded tube designed to monitor the precision of specialty immunoassay testing. This control includes additional complex analytes and is designed to complement Bio-Rad's Immunoassay Plus controls.
InteliQ Tumor Marker Control is a ready-to-use quality control in a barcoded tube designed to monitor the precision of immunoassay based oncology testing.
An unassayed, reactive quality control for the qualitative determination of total IgG/IgM and IgG antibodies to SARS-CoV-2.
An unassayed, non-reactive quality control for the qualitative determination of total IgG/IgM and IgG antibodies to SARS-CoV-2.
A trilevel, liquid, comprehensive serum protein control with assayed values for a wide range of methods; includes Anti-Cyclic Citrullinated Peptide (Anti-CCP) and Rheumatoid Factor (RF).
BioReady Gold Nanospheres - Bare (Citrate) - 40 nm, 20 OD in aqueous 0.02 mM sodium citrate
BioReady Gold Nanospheres - Bare (Citrate) - 80 nm, 20 OD in aqueous 0.02 mM sodium citrate
BioReady Gold Nanospheres - Streptavidin - 40 nm, 10 OD in aqueous conjugation buffer
BioReady Gold Nanoshells - Streptavidin - 150 nm, 10 OD in aqueous conjugation buffer
In children, luteinizing hormone, along with follicle-stimulating hormone, is used to diagnose delayed and precocious (early) puberty. This assay is sensitive to 0.009 mIU/mL and is more appropriate for use in children. This assay offers a 10-fold increase in analytical sensitivity over existing automated immunoassays.
In children, follicle-stimulating hormone along with luteinizing hormone, is used to diagnose delayed and precocious (early) puberty. This assay is sensitive to 0.02 IU/L and is more appropriate for use in children. This assay offers a 10-fold increase in analytical sensitivity over existing automated immunoassays.
Dried blood spot specimen stability makes it a practical alternative to venous blood. Instead of traveling to a clinic to get blood drawn, a blood spot sample can be taken at a convenient site and mailed to a laboratory. It opens new possibilities in testing, such as comparison of historical to current patient results; simplified blood sampling for patients in remote locations, for those who are homebound or those that pre…
Wieslab Diagnostic Services offers a comprehensive range of individual markers and test panels and welcomes samples from customers worldwide. Wiselab's request forms list test panels and individual tests currently available in the areas of Autoimmunity, Neurology, and Monitoring of Biopharmaceuticals. We offer fast turnaround times and access to a medical specialist to discuss your results.
Closed, scalable electroporation system for GMP-compliant cell therapy manufacturing
Closed, scalable electroporation system for GMP-compliant cell therapy manufacturing
The LIAISON® SARS-CoV-2 TrimericS IgG assay enables the reliable detection of Trimeric S spike protein IgG antibodies – the body’s natural defense response against SARS-CoV-2.
The LumiraDx CRP Test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify CRP levels in whole blood and plasma. Used with the LumiraDx Platform, the Test delivers rapid, quantitative results in 4 minutes at the point of care.
The LumiraDx D-Dimer Test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify D-Dimer levels in whole blood and plasma. It is the only direct fingerstick D-Dimer assay available today*, aiding healthcare professionals to exclude deep vein thrombosis (DVT) and pulmonary embolism (PE) in symptomatic patients with confidence** - in only 6 minutes.
The LumiraDx HbA1c test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify HbA1c in fingerstick and venous whole blood. Used with the LumiraDx Platform, the LumiraDx HbA1c test delivers rapid, reliable results in approximately < 7 minutes at the point of care.
The LumiraDx NT-proBNP test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify NT-proBNP in human capillary and venous whole blood and plasma samples (Lithium Heparin). Used with the LumiraDx Platform, the LumiraDx NT-proBNP test delivers rapid, reliable results in 12 minutes at the point of care.
The LumiraDx SARS-CoV-2 Ab Test is a microfluidic immunofluorescence assay for qualitative detection of total antibodies to SARS-CoV-2 in human whole blood (capillary fingerstick or venous), plasma or serum for indication of recent or prior infection. Used with the LumiraDx Platform the Test delivers rapid results at the point of care.
The LumiraDx SARS-CoV-2 Ag Test is a microfluidic immunofluorescence assay for the direct and qualitative detection of nucleocapsid protein antigen in nasal and nasopharyngeal swab specimens from individuals suspected of COVID-19 or asymptomatic individuals. Used with the LumiraDx Platform the test delivers rapid results at the point of care.
